{"gene":"FOXD3","run_date":"2026-04-28T17:46:04","timeline":{"discoveries":[{"year":2002,"finding":"Foxd3 is required for maintenance of pluripotent epiblast cells in the early mouse embryo; Foxd3-/- embryos lose epiblast cells, expand extraembryonic tissues, and cannot establish ES cell lines, demonstrating Foxd3 is essential for progenitor cell maintenance in vivo.","method":"Homozygous knockout mouse, chimera analysis, in vitro blastocyst culture, immunostaining for Oct4/Sox2/Fgf4","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular phenotype, chimera rescue, replicated in multiple assays in one study","pmids":["12381664"],"is_preprint":false},{"year":2001,"finding":"Foxd3 is expressed in premigratory and migratory neural crest cells downstream of Pax3; misexpression of Foxd3 in the chick neural tube promotes neural crest-like fate (HNK1/Cad7 upregulation, delamination, emigration) and suppresses interneuron differentiation, acting independently of Slug and RhoB.","method":"In situ hybridization, chick neural tube electroporation/misexpression, Pax3 mutant mouse analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — gain-of-function in vivo with defined phenotypic readouts, genetic epistasis with Pax3, replicated in two species","pmids":["11684651"],"is_preprint":false},{"year":2001,"finding":"FoxD3 is required for neural crest determination in Xenopus; dominant-negative FoxD3 inhibits neural crest differentiation in vivo without suppressing CNS marker Sox2, and FoxD3 functions upstream of Slug in the neural crest specification pathway.","method":"Dominant-negative FoxD3 construct injection in Xenopus embryos, animal cap explant assays, marker rescue with SLUG co-injection","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function with dominant negative + rescue, genetic epistasis with Slug/Zic, multiple orthogonal methods","pmids":["11493569"],"is_preprint":false},{"year":1998,"finding":"Hfh2 (Foxd3) is expressed in premigratory and migrating neural crest cells in the early mouse embryo and in motor neuron progenitors in the developing spinal cord; the Hfh2 gene was mapped to mouse chromosome 4.","method":"In situ hybridization, immunostaining, linkage analysis","journal":"Mechanisms of development","confidence":"Medium","confidence_rationale":"Tier 3 — direct localization by in situ hybridization, single lab, foundational expression characterization","pmids":["9767163"],"is_preprint":false},{"year":2006,"finding":"Zebrafish foxd3 (sym1 mutant) is required for neural crest specification, migration, and survival: sym1 mutants have normal premigratory neural crest numbers but reduced snai1b and sox10 expression, delayed migration, fewer migratory trunk neural crest cells, and aberrant apoptosis in hindbrain neural crest.","method":"Zebrafish forward genetics (sym1 nucleotide deletion), in situ hybridization for marker genes, TUNEL apoptosis assay","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function with multiple molecular readouts and defined cellular phenotypes","pmids":["16499899"],"is_preprint":false},{"year":2008,"finding":"Foxd3 is required for ES cell self-renewal and survival; conditional deletion of Foxd3 in mouse ESCs causes increased apoptosis, decreased clonal self-renewal, and precocious differentiation along trophectoderm, endoderm, and mesendoderm lineages despite continued Oct4, Sox2, and Nanog expression.","method":"Conditional knockout (tamoxifen-inducible Cre), proliferation/apoptosis assays, clonal self-renewal assay, differentiation marker analysis","journal":"Stem cells (Dayton, Ohio)","confidence":"High","confidence_rationale":"Tier 2 — clean conditional KO with multiple orthogonal phenotypic readouts, single lab","pmids":["18653770"],"is_preprint":false},{"year":2010,"finding":"Foxd3 represses mitfa (MITF-a) transcription to promote iridophore development over melanophore fate in zebrafish; Foxd3 co-localizes with pnp4a in early iridoblasts and is necessary for its expression; double foxd3;mitfa mutants restore iridophore numbers lost in foxd3 single mutants.","method":"Zebrafish genetics (double mutants), in situ hybridization, cell lineage tracing with EosFP photoconvertible marker","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with double mutants + lineage tracing, multiple orthogonal methods","pmids":["20460180"],"is_preprint":false},{"year":2007,"finding":"Hdac1 represses foxd3 expression in neural crest cells to permit mitfa-dependent melanogenesis; in hdac1 mutants foxd3 is overexpressed, reducing mitfa+ melanoblasts; partial knockdown of foxd3 in hdac1 mutants rescues mitfa expression and melanophore defects. Additionally, Foxd3 physically interacts with the mitfa promoter.","method":"Zebrafish hdac1 mutant analysis, foxd3 morpholino knockdown rescue, chromatin/promoter interaction assay for Foxd3 at mitfa promoter","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — genetic interaction/rescue + direct promoter binding assay, multiple methods","pmids":["18068699"],"is_preprint":false},{"year":2011,"finding":"Foxd3 is required in neural crest stem cells to maintain neural potential and repress mesenchymal fates; conditional deletion of Foxd3 in mouse NC cells results in loss of neural derivatives, ectopic vascular smooth muscle in the aorta, precocious osteoblast/chondrocyte differentiation, and a shift from neural to myofibroblast potential at the single-cell level.","method":"Conditional NC-specific Foxd3 knockout mouse, single-cell fate mapping, immunohistochemistry, clonal culture assays","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with single-cell resolution fate assays and multiple derivative analyses","pmids":["21228004"],"is_preprint":false},{"year":2011,"finding":"Foxd3 and Pax3 genetically interact in cardiac neural crest; compound mutants (Foxd3 NC-specific homozygous deletion + Pax3 heterozygous) show fully penetrant persistent truncus arteriosus, severe thymus hypoplasia, increased cell death in neural folds, and near-complete absence of NC caudal to the first pharyngeal arch.","method":"Double mutant mouse genetics, immunohistochemistry, TUNEL assay for cell death","journal":"Genesis (New York, N.Y. : 2000)","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with compound mutant, dose-sensitive interaction, fully penetrant phenotype","pmids":["21254333"],"is_preprint":false},{"year":2011,"finding":"Foxd3 and Tfap2a act together in zebrafish to induce neural crest by maintaining the balance of Bmp and Wnt signaling; double mob;mos mutants completely lack all neural crest-derived tissues; foxd3 overexpression enhances tfap2a-mediated ectopic neural crest induction by overriding neural plate border limits.","method":"Zebrafish double mutant analysis, in situ hybridization, foxd3 mRNA overexpression, Bmp/Wnt pathway marker analysis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — genetic double mutant epistasis + gain-of-function with signaling pathway readouts","pmids":["21963426"],"is_preprint":false},{"year":2012,"finding":"FoxD3 expression in the neural crest is regulated by two distinct enhancers (NC1 and NC2): NC1 drives cranial neural crest expression via Pax7, Msx1/2, and Ets1; NC2 drives vagal/trunk expression via Zic1. These transcription factors directly bind their respective enhancers.","method":"Enhancer reporter assays in chick embryos, in vivo ChIP, morpholino knockdowns, detailed mutational analysis of enhancer elements","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 1–2 — in vivo ChIP + mutagenesis + loss-of-function, multiple orthogonal methods in single rigorous study","pmids":["23284303"],"is_preprint":false},{"year":2013,"finding":"Foxd3 regulates the balance between melanocyte and Schwann cell precursor-derived melanocyte development; gain- and loss-of-function in avians and mice show Foxd3 is sufficient and necessary for this balance, and also sufficient to regulate neuronal vs. glial fate in sensory ganglia.","method":"Avian gain-of-function electroporation, conditional mouse Foxd3 knockout, lineage tracing","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — reciprocal gain/loss-of-function across two species with lineage tracing","pmids":["23858437"],"is_preprint":false},{"year":2016,"finding":"FOXD3 functions as a dual-activator/repressor of enhancers: it recruits the SWI/SNF chromatin remodeling ATPase BRG1 to promote nucleosome removal while simultaneously recruiting histone deacetylases 1/2 to inhibit maximal enhancer activation, thus priming target genes for future expression. FOXD3 switches binding sites as ESCs differentiate to epiblast cells to modulate developmental potential.","method":"ChIP-seq, ATAC-seq, co-immunoprecipitation of FOXD3 with BRG1 and HDAC1/2, conditional FOXD3 deletion, comparison of ESC and EpiSC states","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 1–2 — reconstituted interaction by Co-IP, genome-wide ChIP-seq + chromatin accessibility, conditional KO, multiple orthogonal methods","pmids":["26748757"],"is_preprint":false},{"year":2016,"finding":"Foxd3 is required for exit from naive pluripotency; it acts as a repressor that decommissions active enhancers associated with naive pluripotency and early germline genes during the ESC-to-EpiSC transition, and Foxd3 must subsequently be silenced in primed pluripotent cells to allow PGC specification.","method":"Conditional Foxd3 deletion, ChIP-seq for H3K27ac and H3K4me1, RNA-seq, reporter assays","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 2 — conditional KO + genome-wide chromatin profiling, two orthogonal methods supporting single mechanistic model","pmids":["26748758"],"is_preprint":false},{"year":2013,"finding":"FOXD3 directly binds the NDRG1 promoter and activates its transcription in neuroblastoma cells, thereby suppressing VEGF and MMP9 expression and inhibiting tumor growth, invasion, metastasis, and angiogenesis.","method":"Luciferase reporter assay, ChIP assay, FOXD3 overexpression/knockdown in NB cell lines, xenograft in vivo studies, rescue experiments with NDRG1","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP + reporter assay + rescue, single lab, multiple complementary methods","pmids":["24269992"],"is_preprint":false},{"year":2011,"finding":"FOXD3 upregulation following B-RAF/MEK inhibition (PLX4032/PLX4720) in mutant B-RAF melanoma cells confers resistance to cell death; siRNA knockdown of FOXD3 significantly enhances cell death after PLX4032/4720 treatment, and ectopic FOXD3 expression in non-adherent cells reduces cell death.","method":"siRNA knockdown, ectopic overexpression, PLX4032/PLX4720 drug treatment, cell death assays, non-adherent culture conditions","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — KD and OE with defined phenotypic readouts, single lab, multiple complementary assays","pmids":["21996740"],"is_preprint":false},{"year":2011,"finding":"FOXD3 inhibits migration, invasion, and spheroid outgrowth of mutant B-RAF melanoma cells; FOXD3 is recruited to the Rnd3 promoter and downregulates Rnd3 mRNA and protein, and inhibition of ROCK (downstream of RhoA, which is inhibited by Rnd3) partially restores migration in FOXD3-expressing cells.","method":"Ectopic FOXD3 expression, migration/invasion assays, ChIP at Rnd3 promoter, qRT-PCR, western blot, ROCK inhibitor rescue","journal":"Molecular cancer research : MCR","confidence":"Medium","confidence_rationale":"Tier 2 — direct promoter recruitment by ChIP + functional rescue, single lab","pmids":["21478267"],"is_preprint":false},{"year":2006,"finding":"Foxd3 directly binds the -82/-62 cassette of the myf5 promoter (identified by yeast one-hybrid) and transactivates myf5 expression; foxd3 morpholino knockdown downregulates myf5 in somites and adaxial cells (but not presomitic mesoderm), and is genetically downstream of pax3 in regulating myf5.","method":"Yeast one-hybrid assay, dual-luciferase reporter assay, morpholino knockdown in zebrafish, rescue with foxd3 mRNA","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding by yeast one-hybrid + promoter transactivation + in vivo rescue, single lab","pmids":["16386728"],"is_preprint":false},{"year":2014,"finding":"FoxD3 directly binds the promoter of miR-137 and activates its transcription in hepatocellular carcinoma cells; miR-137 targets AKT2 to inhibit the AKT2/mTOR pathway; FoxD3-regulated miR-137 suppresses HCC growth and metastasis in vivo.","method":"Luciferase reporter assay, ChIP for FOXD3 at miR-137 promoter, miR-137 overexpression/inhibition, AKT2 rescue experiments, xenograft studies","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP + reporter assay + in vivo rescue, single lab with multiple methods","pmids":["24970808"],"is_preprint":false},{"year":2015,"finding":"PAX3 and FOXD3 cooperatively promote CXCR4 expression in melanoma through a conserved intronic enhancer element; inhibition of both factors reduces melanoma cell growth, migration, and motility; these effects are rescued by CXCR4 overexpression, defining a PAX3/FOXD3→CXCR4 regulatory axis.","method":"Transcription factor knockdown/overexpression, reporter assay with intronic CXCR4 enhancer, migration/motility/growth assays, CXCR4 rescue experiments","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — enhancer reporter + KD + OE + rescue, single lab","pmids":["26205821"],"is_preprint":false},{"year":2016,"finding":"FOXD3 directly binds the miR-214 promoter (validated by ChIP assay) and acts as a transcription factor to activate miR-214 expression; miR-214 then targets MED19 to suppress colorectal cancer proliferation, invasion, and metastasis.","method":"ChIP assay for FOXD3 at miR-214 promoter, dual-luciferase reporter assay, bisulphite sequencing, in vitro and in vivo functional assays","journal":"British journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 — direct ChIP binding + reporter validation + in vivo rescue, single lab","pmids":["27811858"],"is_preprint":false},{"year":2011,"finding":"Loss of Foxd3 specifically in pancreatic beta-cells results in impaired glucose tolerance, decreased beta-cell mass, decreased beta-cell proliferation, and decreased beta-cell size during pregnancy; genes regulating proliferation (Foxm1, Skp2, Ezh2, Akt2, Cdkn1a) are misregulated, placing Foxd3 upstream of these proliferative pathways in beta-cells.","method":"Pancreas-specific conditional Foxd3 knockout mouse, glucose tolerance testing, beta-cell mass/proliferation measurements, gene expression profiling of isolated islets","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with defined cellular phenotype + molecular target identification, multiple readouts","pmids":["21952247"],"is_preprint":false},{"year":2013,"finding":"Foxd3 regulates gene expression in murine ESCs controlling embryonic organ development, epithelium development, and epithelial differentiation; direct targets include Sox4, Safb, Sox15, Fosb, Pmaip1, and Smarcd3, identified following conditional Foxd3 deletion and transcriptome analysis.","method":"Conditional Foxd3 deletion, gene expression microarray analysis, validation of novel direct targets","journal":"Stem cell research","confidence":"Medium","confidence_rationale":"Tier 2 — clean conditional KO + transcriptome, single lab, moderate confidence on individual targets without ChIP validation","pmids":["24270162"],"is_preprint":false},{"year":2020,"finding":"FOXD3 regulates VISTA (V-domain Ig suppressor of T cell activation) expression in melanoma; BRAF inhibition upregulates FOXD3 and reduces VISTA expression; melanoma cell-specific VISTA expression promotes tumor onset in vivo and is associated with increased T regulatory cells and enhanced PDL-1 on tumor-infiltrating macrophages.","method":"FOXD3 manipulation (overexpression/knockdown), VISTA expression analysis, in vivo xenograft model, flow cytometry of tumor-infiltrating immune cells","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2/3 — transcriptional regulation link established with in vivo functional consequence, single lab","pmids":["31940493"],"is_preprint":false}],"current_model":"FOXD3 is a forkhead transcription factor that maintains pluripotency and multipotency in embryonic progenitor/stem cells by priming enhancers through recruitment of the SWI/SNF complex (BRG1) while simultaneously repressing them via HDAC1/2 recruitment, promotes neural crest specification downstream of Pax3/Pax7 by activating snai1b/sox10 and suppressing melanocytic fate via direct repression of mitfa, and acts in cancer contexts as a transcriptional activator of tumor-suppressive targets (NDRG1, miR-137, miR-214) and as an adaptive resistance factor following BRAF inhibition in melanoma through repression of migration-associated genes such as Rnd3."},"narrative":{"teleology":[{"year":1998,"claim":"Identifying where FOXD3 is expressed in embryogenesis was the prerequisite for all functional studies: in situ hybridization established its presence in premigratory/migrating neural crest cells and spinal cord motor neuron progenitors.","evidence":"In situ hybridization and immunostaining in mouse embryos","pmids":["9767163"],"confidence":"Medium","gaps":["Expression alone does not demonstrate function","No loss-of-function data at this stage"]},{"year":2001,"claim":"The central question of whether FOXD3 is necessary and sufficient for neural crest specification was resolved: gain-of-function in chick and dominant-negative in Xenopus showed FOXD3 promotes neural crest fate downstream of Pax3 and upstream of Slug, independently of RhoB.","evidence":"Chick neural tube electroporation, Xenopus dominant-negative injection with Slug rescue, Pax3 mutant epistasis","pmids":["11684651","11493569"],"confidence":"High","gaps":["Endogenous loss-of-function in mammals not yet tested","Direct transcriptional targets in neural crest unknown","Mechanism of delamination induction unclear"]},{"year":2002,"claim":"Whether FOXD3 has roles beyond neural crest—specifically in pluripotent stem cells—was answered by the knockout mouse: Foxd3-null embryos lose epiblast cells and fail to establish ES lines, establishing FOXD3 as essential for progenitor cell maintenance.","evidence":"Foxd3 homozygous knockout mouse, chimera analysis, blastocyst outgrowth culture","pmids":["12381664"],"confidence":"High","gaps":["Molecular targets in epiblast not identified","Whether self-renewal or survival is the primary defect was unclear"]},{"year":2006,"claim":"Two studies established direct transcriptional targets of FOXD3: in zebrafish neural crest, foxd3 loss (sym1 mutant) reduced snai1b and sox10 expression during specification; separately, FOXD3 was shown to bind and transactivate the myf5 promoter in somites, revealing tissue-specific target selection.","evidence":"Zebrafish sym1 mutant in situ hybridization; yeast one-hybrid and luciferase reporter for myf5 promoter; morpholino knockdown with rescue","pmids":["16499899","16386728"],"confidence":"High","gaps":["Genome-wide target identification not yet performed","Whether foxd3 directly binds snai1b/sox10 regulatory regions was unknown"]},{"year":2007,"claim":"How FOXD3 controls pigment cell fate was clarified: Foxd3 directly binds and represses the mitfa promoter, and Hdac1 normally silences foxd3 to permit melanogenesis—establishing a Hdac1⊣Foxd3⊣mitfa regulatory hierarchy.","evidence":"Zebrafish hdac1 mutant analysis, foxd3 morpholino rescue of melanophore defects, Foxd3 chromatin/promoter binding at mitfa","pmids":["18068699"],"confidence":"High","gaps":["Whether this hierarchy is conserved in mammals was untested","How Hdac1 silences foxd3 transcription mechanistically was unknown"]},{"year":2008,"claim":"The specific cellular defect in Foxd3-null ESCs was dissected: conditional deletion showed that self-renewal, survival, and lineage restriction all depend on Foxd3, even when Oct4/Sox2/Nanog persist, separating FOXD3 function from the core pluripotency network.","evidence":"Tamoxifen-inducible conditional Foxd3 deletion in mouse ESCs, clonal self-renewal and apoptosis assays","pmids":["18653770"],"confidence":"High","gaps":["Direct chromatin targets in ESCs not mapped","Mechanism of apoptosis suppression unclear"]},{"year":2010,"claim":"Genetic epistasis with double foxd3;mitfa mutants in zebrafish demonstrated that Foxd3's promotion of iridophore fate operates by repressing mitfa—melanocyte commitment is the default that Foxd3 actively blocks.","evidence":"Zebrafish double mutant genetics with lineage tracing using photoconvertible EosFP","pmids":["20460180"],"confidence":"High","gaps":["Positive targets promoting iridophore identity beyond pnp4a not identified","Mammalian relevance untested"]},{"year":2011,"claim":"Multiple studies collectively defined FOXD3's role in maintaining multipotency within the neural crest lineage: conditional deletion in mouse neural crest caused loss of neural derivatives and ectopic mesenchymal fates, compound Foxd3/Pax3 mutants revealed dose-sensitive cooperation in cardiac neural crest survival, and zebrafish double mutants with tfap2a showed complete neural crest ablation.","evidence":"Mouse conditional NC-specific Foxd3 KO with single-cell fate mapping; Foxd3/Pax3 compound mouse mutants; zebrafish foxd3/tfap2a double mutants","pmids":["21228004","21254333","21963426"],"confidence":"High","gaps":["Direct targets maintaining neural potential vs. repressing mesenchymal fate not distinguished genome-wide","Signaling pathways mediating the Foxd3/Tfap2a synergy not fully resolved"]},{"year":2011,"claim":"FOXD3's relevance in cancer was established: BRAF inhibitor treatment upregulates FOXD3 in mutant-BRAF melanoma, conferring adaptive resistance to cell death and suppressing migration/invasion via direct transcriptional repression of Rnd3.","evidence":"siRNA knockdown and ectopic expression in melanoma cell lines treated with PLX4032/PLX4720; ChIP at Rnd3 promoter; ROCK inhibitor rescue","pmids":["21996740","21478267"],"confidence":"Medium","gaps":["In vivo relevance of FOXD3-mediated resistance not demonstrated with genetic models","Upstream mechanism of FOXD3 induction by BRAF inhibition unknown","Single-lab findings for each study"]},{"year":2012,"claim":"The upstream regulation of FOXD3 itself was resolved: two distinct enhancers (NC1, NC2) drive cranial vs. vagal/trunk neural crest expression, with Pax7/Msx1/2/Ets1 directly binding NC1 and Zic1 binding NC2.","evidence":"Enhancer reporter assays in chick, in vivo ChIP, morpholino knockdowns, systematic enhancer mutagenesis","pmids":["23284303"],"confidence":"High","gaps":["Whether these enhancers are conserved and functional in mammals not tested","How signaling pathways converge on these transcription factors at the enhancers is unclear"]},{"year":2013,"claim":"FOXD3's tumor-suppressive transcriptional activity was expanded: it directly binds the NDRG1 promoter to activate transcription in neuroblastoma, suppressing VEGF, MMP9, and metastasis, and regulates melanocyte vs. Schwann cell precursor balance in neural crest derivatives.","evidence":"ChIP and luciferase reporter at NDRG1 promoter, NDRG1 rescue in xenografts; avian gain-of-function and mouse conditional KO with lineage tracing for fate balance","pmids":["24269992","23858437"],"confidence":"Medium","gaps":["NDRG1 regulation by FOXD3 shown in single lab","Whether FOXD3 is silenced in primary neuroblastomas by epigenetic mechanisms needs confirmation"]},{"year":2016,"claim":"The chromatin-level mechanism of FOXD3 was defined: FOXD3 simultaneously recruits BRG1 (SWI/SNF) to open chromatin and HDAC1/2 to prevent full activation, thereby priming enhancers for future expression; it also decommissions naive-pluripotency enhancers during the ESC-to-EpiSC transition and must be silenced for primordial germ cell specification.","evidence":"ChIP-seq, ATAC-seq, co-immunoprecipitation of FOXD3 with BRG1 and HDAC1/2, conditional deletion comparing ESC and EpiSC chromatin states, RNA-seq","pmids":["26748757","26748758"],"confidence":"High","gaps":["Structural basis of FOXD3 interaction with BRG1 and HDAC1/2 unknown","Whether the priming mechanism operates identically in neural crest cells untested","Genome-wide target overlap between ESC and neural crest contexts not compared"]},{"year":2020,"claim":"FOXD3's immunomodulatory dimension in melanoma was uncovered: BRAF inhibition-induced FOXD3 reduces VISTA expression on melanoma cells, and melanoma-specific VISTA promotes tumor onset by expanding T regulatory cells and enhancing PD-L1 on tumor-infiltrating macrophages.","evidence":"FOXD3 overexpression/knockdown in melanoma cells, VISTA expression analysis, in vivo xenograft, flow cytometry of immune infiltrates","pmids":["31940493"],"confidence":"Medium","gaps":["Whether FOXD3 directly binds VISTA regulatory elements not tested (no ChIP)","Single lab, in vivo model is xenograft not syngeneic/autochthonous","Clinical relevance of FOXD3-VISTA axis in BRAF-inhibitor-treated patients unknown"]},{"year":null,"claim":"Key unresolved questions include: how FOXD3's enhancer-priming mechanism in ESCs relates to its function in neural crest and other progenitors; whether the same BRG1/HDAC1/2 co-recruitment operates in all FOXD3-dependent contexts; and what drives the context-dependent switch between FOXD3's activator and repressor activities at specific loci.","evidence":"","pmids":[],"confidence":"Low","gaps":["No genome-wide chromatin profiling of FOXD3 in neural crest cells","Structural basis of FOXD3-cofactor interactions unknown","In vivo genetic validation of FOXD3-mediated drug resistance in melanoma lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[7,13,15,17,18,19,21]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,2,5,6,13,14,15,18,19,21]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[13]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,5,13,14]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[13,14,15,18,19,21]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[13,14]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,2,4,6,8,9,10,11,12]}],"complexes":[],"partners":["BRG1","HDAC1","HDAC2","PAX3","TFAP2A","PAX7"],"other_free_text":[]},"mechanistic_narrative":"FOXD3 is a forkhead-box transcription factor that maintains pluripotency and multipotency in embryonic stem cells and neural crest progenitors by dynamically remodeling enhancer chromatin. In ESCs, FOXD3 primes enhancers by recruiting the SWI/SNF ATPase BRG1 to open chromatin while simultaneously recruiting HDAC1/2 to restrain premature activation, and it decommissions naive-pluripotency enhancers during the transition to primed pluripotency [PMID:26748757, PMID:26748758]. In neural crest development, FOXD3 functions downstream of Pax3/Pax7 and cooperates with Tfap2a to specify neural crest identity, activate snai1b/sox10, maintain neural versus mesenchymal potential, and repress melanocyte fate through direct transcriptional repression of mitfa [PMID:11684651, PMID:16499899, PMID:21228004, PMID:20460180]. In cancer, FOXD3 is upregulated following BRAF inhibition in melanoma where it confers adaptive resistance to cell death and represses migration via Rnd3 downregulation, and it acts as a transcriptional activator of tumor-suppressive targets including NDRG1, miR-137, and miR-214 in other tumor types [PMID:21996740, PMID:21478267, PMID:24269992, PMID:27811858]."},"prefetch_data":{"uniprot":{"accession":"Q9UJU5","full_name":"Forkhead box protein D3","aliases":["HNF3/FH transcription factor genesis"],"length_aa":478,"mass_kda":47.6,"function":"Binds to the consensus sequence 5'-A[AT]T[AG]TTTGTTT-3' and acts as a transcriptional repressor (PubMed:11891324). Also acts as a transcriptional activator (PubMed:11891324). Negatively regulates transcription of transcriptional repressor RHIT/ZNF205 (PubMed:22306510). Promotes development of neural crest cells from neural tube progenitors (PubMed:11891324). Restricts neural progenitor cells to the neural crest lineage while suppressing interneuron differentiation (PubMed:11891324). Required for maintenance of pluripotent cells in the pre-implantation and peri-implantation stages of embryogenesis (PubMed:11891324)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9UJU5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FOXD3","classification":"Not Classified","n_dependent_lines":18,"n_total_lines":1208,"dependency_fraction":0.014900662251655629},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FOXD3","total_profiled":1310},"omim":[{"mim_id":"619720","title":"BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1","url":"https://www.omim.org/entry/619720"},{"mim_id":"619399","title":"TETRASPANIN 18; TSPAN18","url":"https://www.omim.org/entry/619399"},{"mim_id":"618100","title":"MPV17 MITOCHONDRIAL INNER MEMBRANE PROTEIN-LIKE; MPV17L","url":"https://www.omim.org/entry/618100"},{"mim_id":"611539","title":"FORKHEAD BOX D3; FOXD3","url":"https://www.omim.org/entry/611539"},{"mim_id":"608160","title":"SRY-BOX 9; SOX9","url":"https://www.omim.org/entry/608160"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"intestine","ntpm":4.9}],"url":"https://www.proteinatlas.org/search/FOXD3"},"hgnc":{"alias_symbol":["Genesis","HFH2"],"prev_symbol":[]},"alphafold":{"accession":"Q9UJU5","domains":[{"cath_id":"1.10.10.10","chopping":"139-243","consensus_level":"high","plddt":84.7004,"start":139,"end":243}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UJU5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UJU5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UJU5-F1-predicted_aligned_error_v6.png","plddt_mean":55.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FOXD3","jax_strain_url":"https://www.jax.org/strain/search?query=FOXD3"},"sequence":{"accession":"Q9UJU5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UJU5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UJU5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UJU5"}},"corpus_meta":[{"pmid":"11283700","id":"PMC_11283700","title":"To err (meiotically) is human: the genesis of human aneuploidy.","date":"2001","source":"Nature reviews. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11283700","citation_count":1824,"is_preprint":false},{"pmid":"19550425","id":"PMC_19550425","title":"Apoptosis and cancer: the genesis of a research field.","date":"2009","source":"Nature reviews. Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19550425","citation_count":579,"is_preprint":false},{"pmid":"19776209","id":"PMC_19776209","title":"The mammalian ovary from genesis to revelation.","date":"2009","source":"Endocrine reviews","url":"https://pubmed.ncbi.nlm.nih.gov/19776209","citation_count":557,"is_preprint":false},{"pmid":"12040171","id":"PMC_12040171","title":"Specialized DNA polymerases, cellular survival, and the genesis of mutations.","date":"2002","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/12040171","citation_count":359,"is_preprint":false},{"pmid":"16341069","id":"PMC_16341069","title":"The genesis and evolution of homeobox gene clusters.","date":"2005","source":"Nature reviews. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16341069","citation_count":349,"is_preprint":false},{"pmid":"15975993","id":"PMC_15975993","title":"Inflammation in the genesis and perpetuation of atrial fibrillation.","date":"2005","source":"European heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/15975993","citation_count":348,"is_preprint":false},{"pmid":"15164429","id":"PMC_15164429","title":"Timing and topography of cell genesis in the rat retina.","date":"2004","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15164429","citation_count":308,"is_preprint":false},{"pmid":"17804764","id":"PMC_17804764","title":"MicroRNA expression is required for pancreatic islet cell genesis in the mouse.","date":"2007","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/17804764","citation_count":294,"is_preprint":false},{"pmid":"15454629","id":"PMC_15454629","title":"Cell signaling and the genesis of neuropathic pain.","date":"2004","source":"Science's STKE : signal transduction knowledge environment","url":"https://pubmed.ncbi.nlm.nih.gov/15454629","citation_count":279,"is_preprint":false},{"pmid":"17510286","id":"PMC_17510286","title":"Effects of RAS on the genesis of embryonal rhabdomyosarcoma.","date":"2007","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/17510286","citation_count":268,"is_preprint":false},{"pmid":"12381664","id":"PMC_12381664","title":"Requirement for Foxd3 in maintaining pluripotent cells of the early mouse embryo.","date":"2002","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12381664","citation_count":263,"is_preprint":false},{"pmid":"11684651","id":"PMC_11684651","title":"The winged-helix transcription factor Foxd3 suppresses interneuron differentiation and promotes neural crest cell fate.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11684651","citation_count":238,"is_preprint":false},{"pmid":"11493569","id":"PMC_11493569","title":"Requirement of FoxD3-class signaling for neural crest determination in Xenopus.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11493569","citation_count":217,"is_preprint":false},{"pmid":"18296413","id":"PMC_18296413","title":"Genesis and expansion of metazoan transcription factor gene classes.","date":"2008","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/18296413","citation_count":194,"is_preprint":false},{"pmid":"26335954","id":"PMC_26335954","title":"Inflammation and its genesis in cystic fibrosis.","date":"2015","source":"Pediatric pulmonology","url":"https://pubmed.ncbi.nlm.nih.gov/26335954","citation_count":152,"is_preprint":false},{"pmid":"16499899","id":"PMC_16499899","title":"Zebrafish foxd3 is selectively required for neural crest specification, migration and survival.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16499899","citation_count":151,"is_preprint":false},{"pmid":"10817016","id":"PMC_10817016","title":"The pedunculopontine nucleus: its role in the genesis of movement disorders.","date":"2000","source":"Yonsei medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/10817016","citation_count":138,"is_preprint":false},{"pmid":"20460180","id":"PMC_20460180","title":"Interplay between Foxd3 and Mitf regulates cell fate plasticity in the zebrafish neural crest.","date":"2010","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20460180","citation_count":127,"is_preprint":false},{"pmid":"22030549","id":"PMC_22030549","title":"Perivascular instruction of cell genesis and fate in the adult brain.","date":"2011","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22030549","citation_count":127,"is_preprint":false},{"pmid":"23284303","id":"PMC_23284303","title":"Dynamic and differential regulation of stem cell factor FoxD3 in the neural crest is Encrypted in the genome.","date":"2012","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23284303","citation_count":117,"is_preprint":false},{"pmid":"28693893","id":"PMC_28693893","title":"Emerging role for dysregulated decidualization in the genesis of preeclampsia.","date":"2017","source":"Placenta","url":"https://pubmed.ncbi.nlm.nih.gov/28693893","citation_count":117,"is_preprint":false},{"pmid":"22802289","id":"PMC_22802289","title":"Genesis of the myofibroblast in lung injury and fibrosis.","date":"2012","source":"Proceedings of the American Thoracic Society","url":"https://pubmed.ncbi.nlm.nih.gov/22802289","citation_count":108,"is_preprint":false},{"pmid":"19629449","id":"PMC_19629449","title":"Role of cannabis and endocannabinoids in the genesis of schizophrenia.","date":"2009","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19629449","citation_count":107,"is_preprint":false},{"pmid":"1309718","id":"PMC_1309718","title":"Epinephrine and the genesis of hypertension.","date":"1992","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/1309718","citation_count":104,"is_preprint":false},{"pmid":"6450683","id":"PMC_6450683","title":"Meiosis and ascospore genesis in Neurospora.","date":"1980","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/6450683","citation_count":103,"is_preprint":false},{"pmid":"24970808","id":"PMC_24970808","title":"FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2.","date":"2014","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/24970808","citation_count":99,"is_preprint":false},{"pmid":"23858437","id":"PMC_23858437","title":"Neural crest and Schwann cell progenitor-derived melanocytes are two spatially segregated populations similarly regulated by Foxd3.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23858437","citation_count":96,"is_preprint":false},{"pmid":"9767163","id":"PMC_9767163","title":"The winged helix transcription factor Hfh2 is expressed in neural crest and spinal cord during mouse development.","date":"1998","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/9767163","citation_count":94,"is_preprint":false},{"pmid":"21228004","id":"PMC_21228004","title":"Neural crest stem cell multipotency requires Foxd3 to maintain neural potential and repress mesenchymal fates.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21228004","citation_count":92,"is_preprint":false},{"pmid":"21963426","id":"PMC_21963426","title":"Tfap2a and Foxd3 regulate early steps in the development of the neural crest progenitor population.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21963426","citation_count":88,"is_preprint":false},{"pmid":"16549717","id":"PMC_16549717","title":"Sex hormones and the genesis of autoimmunity.","date":"2006","source":"Archives of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/16549717","citation_count":87,"is_preprint":false},{"pmid":"34349258","id":"PMC_34349258","title":"Deficient H2A.Z deposition is associated with genesis of uterine leiomyoma.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34349258","citation_count":86,"is_preprint":false},{"pmid":"18653770","id":"PMC_18653770","title":"Regulation of embryonic stem cell self-renewal and pluripotency by Foxd3.","date":"2008","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/18653770","citation_count":86,"is_preprint":false},{"pmid":"11071767","id":"PMC_11071767","title":"Dynamic expression of neurotrophin receptors during sensory neuron genesis and differentiation.","date":"2000","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11071767","citation_count":84,"is_preprint":false},{"pmid":"300652","id":"PMC_300652","title":"Effect of glucan on granulopoiesis and macrophage genesis in mice.","date":"1977","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/300652","citation_count":84,"is_preprint":false},{"pmid":"30659874","id":"PMC_30659874","title":"The genesis and evolution of bead-based multiplexing.","date":"2019","source":"Methods (San Diego, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/30659874","citation_count":82,"is_preprint":false},{"pmid":"33526371","id":"PMC_33526371","title":"The Retromer Complex: From Genesis to Revelations.","date":"2021","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33526371","citation_count":80,"is_preprint":false},{"pmid":"25172830","id":"PMC_25172830","title":"Genesis and morphogenesis of limb synovial joints and articular cartilage.","date":"2014","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/25172830","citation_count":79,"is_preprint":false},{"pmid":"31969891","id":"PMC_31969891","title":"Singlet Oxygen Metabolism: From Genesis to Signaling.","date":"2020","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/31969891","citation_count":79,"is_preprint":false},{"pmid":"26748757","id":"PMC_26748757","title":"FOXD3 Regulates Pluripotent Stem Cell Potential by Simultaneously Initiating and Repressing Enhancer Activity.","date":"2016","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/26748757","citation_count":79,"is_preprint":false},{"pmid":"23880362","id":"PMC_23880362","title":"Mesenchymal stem cell transformation and sarcoma genesis.","date":"2013","source":"Clinical sarcoma research","url":"https://pubmed.ncbi.nlm.nih.gov/23880362","citation_count":79,"is_preprint":false},{"pmid":"20106549","id":"PMC_20106549","title":"Running reduces stress and enhances cell genesis in aged mice.","date":"2010","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/20106549","citation_count":74,"is_preprint":false},{"pmid":"21147195","id":"PMC_21147195","title":"Mitochondrial protein import and the genesis of steroidogenic mitochondria.","date":"2010","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21147195","citation_count":73,"is_preprint":false},{"pmid":"31940493","id":"PMC_31940493","title":"FOXD3 Regulates VISTA Expression in Melanoma.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31940493","citation_count":70,"is_preprint":false},{"pmid":"30830899","id":"PMC_30830899","title":"Genesis of the αβ T-cell receptor.","date":"2019","source":"PLoS computational biology","url":"https://pubmed.ncbi.nlm.nih.gov/30830899","citation_count":70,"is_preprint":false},{"pmid":"26748758","id":"PMC_26748758","title":"Foxd3 Promotes Exit from Naive Pluripotency through Enhancer Decommissioning and Inhibits Germline Specification.","date":"2016","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/26748758","citation_count":67,"is_preprint":false},{"pmid":"18068699","id":"PMC_18068699","title":"colgate/hdac1 Repression of foxd3 expression is required to permit mitfa-dependent melanogenesis.","date":"2007","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18068699","citation_count":64,"is_preprint":false},{"pmid":"24269992","id":"PMC_24269992","title":"FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma.","date":"2013","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/24269992","citation_count":63,"is_preprint":false},{"pmid":"14598366","id":"PMC_14598366","title":"Slow axonal transport and the genesis of neuronal morphology.","date":"2004","source":"Journal of neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/14598366","citation_count":62,"is_preprint":false},{"pmid":"28655711","id":"PMC_28655711","title":"Long noncoding RNA FOXD3-AS1 regulates oxidative stress-induced apoptosis via sponging microRNA-150.","date":"2017","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/28655711","citation_count":60,"is_preprint":false},{"pmid":"23926259","id":"PMC_23926259","title":"Onecut1 is essential for horizontal cell genesis and retinal integrity.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23926259","citation_count":60,"is_preprint":false},{"pmid":"33498529","id":"PMC_33498529","title":"Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33498529","citation_count":59,"is_preprint":false},{"pmid":"29398485","id":"PMC_29398485","title":"Retracted: Risk-Associated Long Noncoding RNA FOXD3-AS1 Inhibits Neuroblastoma Progression by Repressing PARP1-Mediated Activation of CTCF.","date":"2017","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29398485","citation_count":58,"is_preprint":false},{"pmid":"24411700","id":"PMC_24411700","title":"Physiological protein aggregation run amuck: stress granules and the genesis of neurodegenerative disease.","date":"2014","source":"Discovery medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24411700","citation_count":57,"is_preprint":false},{"pmid":"26635811","id":"PMC_26635811","title":"Macrophage and Innate Lymphoid Cell Interplay in the Genesis of Fibrosis.","date":"2015","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26635811","citation_count":55,"is_preprint":false},{"pmid":"21996740","id":"PMC_21996740","title":"Adaptive upregulation of FOXD3 and resistance to PLX4032/4720-induced cell death in mutant B-RAF melanoma cells.","date":"2011","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/21996740","citation_count":55,"is_preprint":false},{"pmid":"37339578","id":"PMC_37339578","title":"The genesis of human hematopoietic stem cells.","date":"2023","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/37339578","citation_count":51,"is_preprint":false},{"pmid":"27660268","id":"PMC_27660268","title":"Role of STAT3 in Genesis and Progression of Human Malignant Gliomas.","date":"2016","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/27660268","citation_count":51,"is_preprint":false},{"pmid":"27926503","id":"PMC_27926503","title":"FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27926503","citation_count":49,"is_preprint":false},{"pmid":"25993993","id":"PMC_25993993","title":"A Place at the Table: LTD as a Mediator of Memory Genesis.","date":"2015","source":"The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25993993","citation_count":47,"is_preprint":false},{"pmid":"24920186","id":"PMC_24920186","title":"Using zebrafish to study podocyte genesis during kidney development and regeneration.","date":"2014","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/24920186","citation_count":47,"is_preprint":false},{"pmid":"15456524","id":"PMC_15456524","title":"Causative and preventive action of calcium in cataracto-genesis.","date":"2004","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/15456524","citation_count":46,"is_preprint":false},{"pmid":"8102106","id":"PMC_8102106","title":"The role of gene mutations in the genesis of familial cancers.","date":"1993","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/8102106","citation_count":46,"is_preprint":false},{"pmid":"26958905","id":"PMC_26958905","title":"The Legacy of Nat Sternberg: The Genesis of Cre-lox Technology.","date":"2015","source":"Annual review of virology","url":"https://pubmed.ncbi.nlm.nih.gov/26958905","citation_count":39,"is_preprint":false},{"pmid":"27811858","id":"PMC_27811858","title":"The FOXD3/miR-214/MED19 axis suppresses tumour growth and metastasis in human colorectal cancer.","date":"2016","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27811858","citation_count":39,"is_preprint":false},{"pmid":"16386728","id":"PMC_16386728","title":"Foxd3 mediates zebrafish myf5 expression during early somitogenesis.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16386728","citation_count":39,"is_preprint":false},{"pmid":"24924147","id":"PMC_24924147","title":"Peroxidasins: novel players in tissue genesis.","date":"2014","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24924147","citation_count":38,"is_preprint":false},{"pmid":"21478267","id":"PMC_21478267","title":"FOXD3 regulates migration properties and Rnd3 expression in melanoma cells.","date":"2011","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/21478267","citation_count":38,"is_preprint":false},{"pmid":"30987631","id":"PMC_30987631","title":"Genes CEP55, FOXD3, FOXF2, GNAO1, GRIA4, and KCNA5 as potential diagnostic biomarkers in colorectal cancer.","date":"2019","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/30987631","citation_count":38,"is_preprint":false},{"pmid":"8931090","id":"PMC_8931090","title":"Spatiotemporal gradients of cell genesis in the primate retina.","date":"1996","source":"Perspectives on developmental neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/8931090","citation_count":38,"is_preprint":false},{"pmid":"16055545","id":"PMC_16055545","title":"Genesis of ectopic waves: role of coupling, automaticity, and heterogeneity.","date":"2005","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16055545","citation_count":37,"is_preprint":false},{"pmid":"33571665","id":"PMC_33571665","title":"Role of inflammatory cytokines in genesis and treatment of atherosclerosis.","date":"2021","source":"Trends in cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33571665","citation_count":37,"is_preprint":false},{"pmid":"2942331","id":"PMC_2942331","title":"Platelet and vessel wall interaction and the genesis of atherosclerosis.","date":"1986","source":"Clinics in haematology","url":"https://pubmed.ncbi.nlm.nih.gov/2942331","citation_count":36,"is_preprint":false},{"pmid":"28167050","id":"PMC_28167050","title":"Changing mutational and adaptive landscapes and the genesis of cancer.","date":"2017","source":"Biochimica et biophysica acta. Reviews on cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28167050","citation_count":34,"is_preprint":false},{"pmid":"19631262","id":"PMC_19631262","title":"Retrotransposons, reverse transcriptase and the genesis of new genetic information.","date":"2009","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/19631262","citation_count":34,"is_preprint":false},{"pmid":"37294111","id":"PMC_37294111","title":"Genesis of clinical and subclinical endometritis in dairy cows.","date":"2023","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/37294111","citation_count":32,"is_preprint":false},{"pmid":"33782712","id":"PMC_33782712","title":"Genetic control of retinal ganglion cell genesis.","date":"2021","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/33782712","citation_count":30,"is_preprint":false},{"pmid":"31632535","id":"PMC_31632535","title":"Long non-coding RNA FOXD3-AS1 aggravates ischemia/reperfusion injury of cardiomyocytes through promoting autophagy.","date":"2019","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/31632535","citation_count":30,"is_preprint":false},{"pmid":"35359410","id":"PMC_35359410","title":"The Subventricular Zone in Glioblastoma: Genesis, Maintenance, and Modeling.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35359410","citation_count":29,"is_preprint":false},{"pmid":"27865628","id":"PMC_27865628","title":"The genesis and presentation of anxiety in disorders of autonomic overexcitation.","date":"2016","source":"Autonomic neuroscience : basic & clinical","url":"https://pubmed.ncbi.nlm.nih.gov/27865628","citation_count":29,"is_preprint":false},{"pmid":"32743522","id":"PMC_32743522","title":"Immune-mediated genesis of multiple sclerosis.","date":"2020","source":"Journal of translational autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/32743522","citation_count":28,"is_preprint":false},{"pmid":"24479800","id":"PMC_24479800","title":"Oncogenic microRNAs in the genesis of leukemia and lymphoma.","date":"2014","source":"Current pharmaceutical design","url":"https://pubmed.ncbi.nlm.nih.gov/24479800","citation_count":28,"is_preprint":false},{"pmid":"1194788","id":"PMC_1194788","title":"Genesis of fatty liver and hyperlipemia in the fetal guinea pig.","date":"1975","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/1194788","citation_count":28,"is_preprint":false},{"pmid":"21952247","id":"PMC_21952247","title":"Loss of Foxd3 results in decreased β-cell proliferation and glucose intolerance during pregnancy.","date":"2011","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21952247","citation_count":26,"is_preprint":false},{"pmid":"21912849","id":"PMC_21912849","title":"Novel concepts in the genesis of hypertension: role of LOX-1.","date":"2011","source":"Cardiovascular drugs and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/21912849","citation_count":26,"is_preprint":false},{"pmid":"23178582","id":"PMC_23178582","title":"The role of stem cells and progenitors in the genesis of medulloblastoma.","date":"2012","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23178582","citation_count":25,"is_preprint":false},{"pmid":"34270934","id":"PMC_34270934","title":"Fractalkine signaling regulates oligodendroglial cell genesis from SVZ precursor cells.","date":"2021","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/34270934","citation_count":25,"is_preprint":false},{"pmid":"36435829","id":"PMC_36435829","title":"Creb5 coordinates synovial joint formation with the genesis of articular cartilage.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36435829","citation_count":25,"is_preprint":false},{"pmid":"26341266","id":"PMC_26341266","title":"FOXD3 suppresses tumor growth and angiogenesis in non-small cell lung cancer.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/26341266","citation_count":24,"is_preprint":false},{"pmid":"33903757","id":"PMC_33903757","title":"Creating custom synthetic genomes in Escherichia coli with REXER and GENESIS.","date":"2021","source":"Nature protocols","url":"https://pubmed.ncbi.nlm.nih.gov/33903757","citation_count":23,"is_preprint":false},{"pmid":"24270162","id":"PMC_24270162","title":"Transcriptional targets of Foxd3 in murine ES cells.","date":"2013","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/24270162","citation_count":22,"is_preprint":false},{"pmid":"21254333","id":"PMC_21254333","title":"Functional interaction between Foxd3 and Pax3 in cardiac neural crest development.","date":"2010","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/21254333","citation_count":22,"is_preprint":false},{"pmid":"19568590","id":"PMC_19568590","title":"Promoter methylation in the genesis of gastrointestinal cancer.","date":"2009","source":"Yonsei medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/19568590","citation_count":22,"is_preprint":false},{"pmid":"33706104","id":"PMC_33706104","title":"MiR-328-3p inhibits lung adenocarcinoma-genesis by downregulation PYCR1.","date":"2021","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/33706104","citation_count":22,"is_preprint":false},{"pmid":"26205821","id":"PMC_26205821","title":"PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26205821","citation_count":21,"is_preprint":false},{"pmid":"30315543","id":"PMC_30315543","title":"Microcalcifications, Their Genesis, Growth, and Biomechanical Stability in Fibrous Cap Rupture.","date":"2018","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/30315543","citation_count":21,"is_preprint":false},{"pmid":"33244270","id":"PMC_33244270","title":"MiR-582-5p Inhibits Bladder Cancer-Genesis by Suppressing TTK Expression.","date":"2020","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/33244270","citation_count":21,"is_preprint":false},{"pmid":"28320475","id":"PMC_28320475","title":"Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.","date":"2017","source":"World journal of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/28320475","citation_count":21,"is_preprint":false},{"pmid":"19190696","id":"PMC_19190696","title":"Microbial genesis, life and death in glacial ice.","date":"2009","source":"Canadian journal of microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/19190696","citation_count":21,"is_preprint":false},{"pmid":"1336648","id":"PMC_1336648","title":"Cell-matrix interactions in the genesis of arteriosclerosis and atheroma. Effect of aging.","date":"1992","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/1336648","citation_count":20,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":41716,"output_tokens":5765,"usd":0.105812},"stage2":{"model":"claude-opus-4-6","input_tokens":9349,"output_tokens":3643,"usd":0.20673},"total_usd":0.312542,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"Foxd3 is required for maintenance of pluripotent epiblast cells in the early mouse embryo; Foxd3-/- embryos lose epiblast cells, expand extraembryonic tissues, and cannot establish ES cell lines, demonstrating Foxd3 is essential for progenitor cell maintenance in vivo.\",\n      \"method\": \"Homozygous knockout mouse, chimera analysis, in vitro blastocyst culture, immunostaining for Oct4/Sox2/Fgf4\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype, chimera rescue, replicated in multiple assays in one study\",\n      \"pmids\": [\"12381664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Foxd3 is expressed in premigratory and migratory neural crest cells downstream of Pax3; misexpression of Foxd3 in the chick neural tube promotes neural crest-like fate (HNK1/Cad7 upregulation, delamination, emigration) and suppresses interneuron differentiation, acting independently of Slug and RhoB.\",\n      \"method\": \"In situ hybridization, chick neural tube electroporation/misexpression, Pax3 mutant mouse analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function in vivo with defined phenotypic readouts, genetic epistasis with Pax3, replicated in two species\",\n      \"pmids\": [\"11684651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"FoxD3 is required for neural crest determination in Xenopus; dominant-negative FoxD3 inhibits neural crest differentiation in vivo without suppressing CNS marker Sox2, and FoxD3 functions upstream of Slug in the neural crest specification pathway.\",\n      \"method\": \"Dominant-negative FoxD3 construct injection in Xenopus embryos, animal cap explant assays, marker rescue with SLUG co-injection\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with dominant negative + rescue, genetic epistasis with Slug/Zic, multiple orthogonal methods\",\n      \"pmids\": [\"11493569\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Hfh2 (Foxd3) is expressed in premigratory and migrating neural crest cells in the early mouse embryo and in motor neuron progenitors in the developing spinal cord; the Hfh2 gene was mapped to mouse chromosome 4.\",\n      \"method\": \"In situ hybridization, immunostaining, linkage analysis\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct localization by in situ hybridization, single lab, foundational expression characterization\",\n      \"pmids\": [\"9767163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Zebrafish foxd3 (sym1 mutant) is required for neural crest specification, migration, and survival: sym1 mutants have normal premigratory neural crest numbers but reduced snai1b and sox10 expression, delayed migration, fewer migratory trunk neural crest cells, and aberrant apoptosis in hindbrain neural crest.\",\n      \"method\": \"Zebrafish forward genetics (sym1 nucleotide deletion), in situ hybridization for marker genes, TUNEL apoptosis assay\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with multiple molecular readouts and defined cellular phenotypes\",\n      \"pmids\": [\"16499899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Foxd3 is required for ES cell self-renewal and survival; conditional deletion of Foxd3 in mouse ESCs causes increased apoptosis, decreased clonal self-renewal, and precocious differentiation along trophectoderm, endoderm, and mesendoderm lineages despite continued Oct4, Sox2, and Nanog expression.\",\n      \"method\": \"Conditional knockout (tamoxifen-inducible Cre), proliferation/apoptosis assays, clonal self-renewal assay, differentiation marker analysis\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean conditional KO with multiple orthogonal phenotypic readouts, single lab\",\n      \"pmids\": [\"18653770\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Foxd3 represses mitfa (MITF-a) transcription to promote iridophore development over melanophore fate in zebrafish; Foxd3 co-localizes with pnp4a in early iridoblasts and is necessary for its expression; double foxd3;mitfa mutants restore iridophore numbers lost in foxd3 single mutants.\",\n      \"method\": \"Zebrafish genetics (double mutants), in situ hybridization, cell lineage tracing with EosFP photoconvertible marker\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with double mutants + lineage tracing, multiple orthogonal methods\",\n      \"pmids\": [\"20460180\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Hdac1 represses foxd3 expression in neural crest cells to permit mitfa-dependent melanogenesis; in hdac1 mutants foxd3 is overexpressed, reducing mitfa+ melanoblasts; partial knockdown of foxd3 in hdac1 mutants rescues mitfa expression and melanophore defects. Additionally, Foxd3 physically interacts with the mitfa promoter.\",\n      \"method\": \"Zebrafish hdac1 mutant analysis, foxd3 morpholino knockdown rescue, chromatin/promoter interaction assay for Foxd3 at mitfa promoter\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic interaction/rescue + direct promoter binding assay, multiple methods\",\n      \"pmids\": [\"18068699\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Foxd3 is required in neural crest stem cells to maintain neural potential and repress mesenchymal fates; conditional deletion of Foxd3 in mouse NC cells results in loss of neural derivatives, ectopic vascular smooth muscle in the aorta, precocious osteoblast/chondrocyte differentiation, and a shift from neural to myofibroblast potential at the single-cell level.\",\n      \"method\": \"Conditional NC-specific Foxd3 knockout mouse, single-cell fate mapping, immunohistochemistry, clonal culture assays\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with single-cell resolution fate assays and multiple derivative analyses\",\n      \"pmids\": [\"21228004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Foxd3 and Pax3 genetically interact in cardiac neural crest; compound mutants (Foxd3 NC-specific homozygous deletion + Pax3 heterozygous) show fully penetrant persistent truncus arteriosus, severe thymus hypoplasia, increased cell death in neural folds, and near-complete absence of NC caudal to the first pharyngeal arch.\",\n      \"method\": \"Double mutant mouse genetics, immunohistochemistry, TUNEL assay for cell death\",\n      \"journal\": \"Genesis (New York, N.Y. : 2000)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with compound mutant, dose-sensitive interaction, fully penetrant phenotype\",\n      \"pmids\": [\"21254333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Foxd3 and Tfap2a act together in zebrafish to induce neural crest by maintaining the balance of Bmp and Wnt signaling; double mob;mos mutants completely lack all neural crest-derived tissues; foxd3 overexpression enhances tfap2a-mediated ectopic neural crest induction by overriding neural plate border limits.\",\n      \"method\": \"Zebrafish double mutant analysis, in situ hybridization, foxd3 mRNA overexpression, Bmp/Wnt pathway marker analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic double mutant epistasis + gain-of-function with signaling pathway readouts\",\n      \"pmids\": [\"21963426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"FoxD3 expression in the neural crest is regulated by two distinct enhancers (NC1 and NC2): NC1 drives cranial neural crest expression via Pax7, Msx1/2, and Ets1; NC2 drives vagal/trunk expression via Zic1. These transcription factors directly bind their respective enhancers.\",\n      \"method\": \"Enhancer reporter assays in chick embryos, in vivo ChIP, morpholino knockdowns, detailed mutational analysis of enhancer elements\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vivo ChIP + mutagenesis + loss-of-function, multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"23284303\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Foxd3 regulates the balance between melanocyte and Schwann cell precursor-derived melanocyte development; gain- and loss-of-function in avians and mice show Foxd3 is sufficient and necessary for this balance, and also sufficient to regulate neuronal vs. glial fate in sensory ganglia.\",\n      \"method\": \"Avian gain-of-function electroporation, conditional mouse Foxd3 knockout, lineage tracing\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain/loss-of-function across two species with lineage tracing\",\n      \"pmids\": [\"23858437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"FOXD3 functions as a dual-activator/repressor of enhancers: it recruits the SWI/SNF chromatin remodeling ATPase BRG1 to promote nucleosome removal while simultaneously recruiting histone deacetylases 1/2 to inhibit maximal enhancer activation, thus priming target genes for future expression. FOXD3 switches binding sites as ESCs differentiate to epiblast cells to modulate developmental potential.\",\n      \"method\": \"ChIP-seq, ATAC-seq, co-immunoprecipitation of FOXD3 with BRG1 and HDAC1/2, conditional FOXD3 deletion, comparison of ESC and EpiSC states\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reconstituted interaction by Co-IP, genome-wide ChIP-seq + chromatin accessibility, conditional KO, multiple orthogonal methods\",\n      \"pmids\": [\"26748757\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Foxd3 is required for exit from naive pluripotency; it acts as a repressor that decommissions active enhancers associated with naive pluripotency and early germline genes during the ESC-to-EpiSC transition, and Foxd3 must subsequently be silenced in primed pluripotent cells to allow PGC specification.\",\n      \"method\": \"Conditional Foxd3 deletion, ChIP-seq for H3K27ac and H3K4me1, RNA-seq, reporter assays\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO + genome-wide chromatin profiling, two orthogonal methods supporting single mechanistic model\",\n      \"pmids\": [\"26748758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"FOXD3 directly binds the NDRG1 promoter and activates its transcription in neuroblastoma cells, thereby suppressing VEGF and MMP9 expression and inhibiting tumor growth, invasion, metastasis, and angiogenesis.\",\n      \"method\": \"Luciferase reporter assay, ChIP assay, FOXD3 overexpression/knockdown in NB cell lines, xenograft in vivo studies, rescue experiments with NDRG1\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP + reporter assay + rescue, single lab, multiple complementary methods\",\n      \"pmids\": [\"24269992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"FOXD3 upregulation following B-RAF/MEK inhibition (PLX4032/PLX4720) in mutant B-RAF melanoma cells confers resistance to cell death; siRNA knockdown of FOXD3 significantly enhances cell death after PLX4032/4720 treatment, and ectopic FOXD3 expression in non-adherent cells reduces cell death.\",\n      \"method\": \"siRNA knockdown, ectopic overexpression, PLX4032/PLX4720 drug treatment, cell death assays, non-adherent culture conditions\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD and OE with defined phenotypic readouts, single lab, multiple complementary assays\",\n      \"pmids\": [\"21996740\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"FOXD3 inhibits migration, invasion, and spheroid outgrowth of mutant B-RAF melanoma cells; FOXD3 is recruited to the Rnd3 promoter and downregulates Rnd3 mRNA and protein, and inhibition of ROCK (downstream of RhoA, which is inhibited by Rnd3) partially restores migration in FOXD3-expressing cells.\",\n      \"method\": \"Ectopic FOXD3 expression, migration/invasion assays, ChIP at Rnd3 promoter, qRT-PCR, western blot, ROCK inhibitor rescue\",\n      \"journal\": \"Molecular cancer research : MCR\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter recruitment by ChIP + functional rescue, single lab\",\n      \"pmids\": [\"21478267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Foxd3 directly binds the -82/-62 cassette of the myf5 promoter (identified by yeast one-hybrid) and transactivates myf5 expression; foxd3 morpholino knockdown downregulates myf5 in somites and adaxial cells (but not presomitic mesoderm), and is genetically downstream of pax3 in regulating myf5.\",\n      \"method\": \"Yeast one-hybrid assay, dual-luciferase reporter assay, morpholino knockdown in zebrafish, rescue with foxd3 mRNA\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding by yeast one-hybrid + promoter transactivation + in vivo rescue, single lab\",\n      \"pmids\": [\"16386728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"FoxD3 directly binds the promoter of miR-137 and activates its transcription in hepatocellular carcinoma cells; miR-137 targets AKT2 to inhibit the AKT2/mTOR pathway; FoxD3-regulated miR-137 suppresses HCC growth and metastasis in vivo.\",\n      \"method\": \"Luciferase reporter assay, ChIP for FOXD3 at miR-137 promoter, miR-137 overexpression/inhibition, AKT2 rescue experiments, xenograft studies\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP + reporter assay + in vivo rescue, single lab with multiple methods\",\n      \"pmids\": [\"24970808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PAX3 and FOXD3 cooperatively promote CXCR4 expression in melanoma through a conserved intronic enhancer element; inhibition of both factors reduces melanoma cell growth, migration, and motility; these effects are rescued by CXCR4 overexpression, defining a PAX3/FOXD3→CXCR4 regulatory axis.\",\n      \"method\": \"Transcription factor knockdown/overexpression, reporter assay with intronic CXCR4 enhancer, migration/motility/growth assays, CXCR4 rescue experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — enhancer reporter + KD + OE + rescue, single lab\",\n      \"pmids\": [\"26205821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"FOXD3 directly binds the miR-214 promoter (validated by ChIP assay) and acts as a transcription factor to activate miR-214 expression; miR-214 then targets MED19 to suppress colorectal cancer proliferation, invasion, and metastasis.\",\n      \"method\": \"ChIP assay for FOXD3 at miR-214 promoter, dual-luciferase reporter assay, bisulphite sequencing, in vitro and in vivo functional assays\",\n      \"journal\": \"British journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct ChIP binding + reporter validation + in vivo rescue, single lab\",\n      \"pmids\": [\"27811858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Loss of Foxd3 specifically in pancreatic beta-cells results in impaired glucose tolerance, decreased beta-cell mass, decreased beta-cell proliferation, and decreased beta-cell size during pregnancy; genes regulating proliferation (Foxm1, Skp2, Ezh2, Akt2, Cdkn1a) are misregulated, placing Foxd3 upstream of these proliferative pathways in beta-cells.\",\n      \"method\": \"Pancreas-specific conditional Foxd3 knockout mouse, glucose tolerance testing, beta-cell mass/proliferation measurements, gene expression profiling of isolated islets\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with defined cellular phenotype + molecular target identification, multiple readouts\",\n      \"pmids\": [\"21952247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Foxd3 regulates gene expression in murine ESCs controlling embryonic organ development, epithelium development, and epithelial differentiation; direct targets include Sox4, Safb, Sox15, Fosb, Pmaip1, and Smarcd3, identified following conditional Foxd3 deletion and transcriptome analysis.\",\n      \"method\": \"Conditional Foxd3 deletion, gene expression microarray analysis, validation of novel direct targets\",\n      \"journal\": \"Stem cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean conditional KO + transcriptome, single lab, moderate confidence on individual targets without ChIP validation\",\n      \"pmids\": [\"24270162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"FOXD3 regulates VISTA (V-domain Ig suppressor of T cell activation) expression in melanoma; BRAF inhibition upregulates FOXD3 and reduces VISTA expression; melanoma cell-specific VISTA expression promotes tumor onset in vivo and is associated with increased T regulatory cells and enhanced PDL-1 on tumor-infiltrating macrophages.\",\n      \"method\": \"FOXD3 manipulation (overexpression/knockdown), VISTA expression analysis, in vivo xenograft model, flow cytometry of tumor-infiltrating immune cells\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — transcriptional regulation link established with in vivo functional consequence, single lab\",\n      \"pmids\": [\"31940493\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FOXD3 is a forkhead transcription factor that maintains pluripotency and multipotency in embryonic progenitor/stem cells by priming enhancers through recruitment of the SWI/SNF complex (BRG1) while simultaneously repressing them via HDAC1/2 recruitment, promotes neural crest specification downstream of Pax3/Pax7 by activating snai1b/sox10 and suppressing melanocytic fate via direct repression of mitfa, and acts in cancer contexts as a transcriptional activator of tumor-suppressive targets (NDRG1, miR-137, miR-214) and as an adaptive resistance factor following BRAF inhibition in melanoma through repression of migration-associated genes such as Rnd3.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"FOXD3 is a forkhead-box transcription factor that maintains pluripotency and multipotency in embryonic stem cells and neural crest progenitors by dynamically remodeling enhancer chromatin. In ESCs, FOXD3 primes enhancers by recruiting the SWI/SNF ATPase BRG1 to open chromatin while simultaneously recruiting HDAC1/2 to restrain premature activation, and it decommissions naive-pluripotency enhancers during the transition to primed pluripotency [PMID:26748757, PMID:26748758]. In neural crest development, FOXD3 functions downstream of Pax3/Pax7 and cooperates with Tfap2a to specify neural crest identity, activate snai1b/sox10, maintain neural versus mesenchymal potential, and repress melanocyte fate through direct transcriptional repression of mitfa [PMID:11684651, PMID:16499899, PMID:21228004, PMID:20460180]. In cancer, FOXD3 is upregulated following BRAF inhibition in melanoma where it confers adaptive resistance to cell death and represses migration via Rnd3 downregulation, and it acts as a transcriptional activator of tumor-suppressive targets including NDRG1, miR-137, and miR-214 in other tumor types [PMID:21996740, PMID:21478267, PMID:24269992, PMID:27811858].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Identifying where FOXD3 is expressed in embryogenesis was the prerequisite for all functional studies: in situ hybridization established its presence in premigratory/migrating neural crest cells and spinal cord motor neuron progenitors.\",\n      \"evidence\": \"In situ hybridization and immunostaining in mouse embryos\",\n      \"pmids\": [\"9767163\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Expression alone does not demonstrate function\", \"No loss-of-function data at this stage\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"The central question of whether FOXD3 is necessary and sufficient for neural crest specification was resolved: gain-of-function in chick and dominant-negative in Xenopus showed FOXD3 promotes neural crest fate downstream of Pax3 and upstream of Slug, independently of RhoB.\",\n      \"evidence\": \"Chick neural tube electroporation, Xenopus dominant-negative injection with Slug rescue, Pax3 mutant epistasis\",\n      \"pmids\": [\"11684651\", \"11493569\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous loss-of-function in mammals not yet tested\", \"Direct transcriptional targets in neural crest unknown\", \"Mechanism of delamination induction unclear\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Whether FOXD3 has roles beyond neural crest—specifically in pluripotent stem cells—was answered by the knockout mouse: Foxd3-null embryos lose epiblast cells and fail to establish ES lines, establishing FOXD3 as essential for progenitor cell maintenance.\",\n      \"evidence\": \"Foxd3 homozygous knockout mouse, chimera analysis, blastocyst outgrowth culture\",\n      \"pmids\": [\"12381664\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular targets in epiblast not identified\", \"Whether self-renewal or survival is the primary defect was unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Two studies established direct transcriptional targets of FOXD3: in zebrafish neural crest, foxd3 loss (sym1 mutant) reduced snai1b and sox10 expression during specification; separately, FOXD3 was shown to bind and transactivate the myf5 promoter in somites, revealing tissue-specific target selection.\",\n      \"evidence\": \"Zebrafish sym1 mutant in situ hybridization; yeast one-hybrid and luciferase reporter for myf5 promoter; morpholino knockdown with rescue\",\n      \"pmids\": [\"16499899\", \"16386728\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide target identification not yet performed\", \"Whether foxd3 directly binds snai1b/sox10 regulatory regions was unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"How FOXD3 controls pigment cell fate was clarified: Foxd3 directly binds and represses the mitfa promoter, and Hdac1 normally silences foxd3 to permit melanogenesis—establishing a Hdac1⊣Foxd3⊣mitfa regulatory hierarchy.\",\n      \"evidence\": \"Zebrafish hdac1 mutant analysis, foxd3 morpholino rescue of melanophore defects, Foxd3 chromatin/promoter binding at mitfa\",\n      \"pmids\": [\"18068699\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this hierarchy is conserved in mammals was untested\", \"How Hdac1 silences foxd3 transcription mechanistically was unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The specific cellular defect in Foxd3-null ESCs was dissected: conditional deletion showed that self-renewal, survival, and lineage restriction all depend on Foxd3, even when Oct4/Sox2/Nanog persist, separating FOXD3 function from the core pluripotency network.\",\n      \"evidence\": \"Tamoxifen-inducible conditional Foxd3 deletion in mouse ESCs, clonal self-renewal and apoptosis assays\",\n      \"pmids\": [\"18653770\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct chromatin targets in ESCs not mapped\", \"Mechanism of apoptosis suppression unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Genetic epistasis with double foxd3;mitfa mutants in zebrafish demonstrated that Foxd3's promotion of iridophore fate operates by repressing mitfa—melanocyte commitment is the default that Foxd3 actively blocks.\",\n      \"evidence\": \"Zebrafish double mutant genetics with lineage tracing using photoconvertible EosFP\",\n      \"pmids\": [\"20460180\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Positive targets promoting iridophore identity beyond pnp4a not identified\", \"Mammalian relevance untested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Multiple studies collectively defined FOXD3's role in maintaining multipotency within the neural crest lineage: conditional deletion in mouse neural crest caused loss of neural derivatives and ectopic mesenchymal fates, compound Foxd3/Pax3 mutants revealed dose-sensitive cooperation in cardiac neural crest survival, and zebrafish double mutants with tfap2a showed complete neural crest ablation.\",\n      \"evidence\": \"Mouse conditional NC-specific Foxd3 KO with single-cell fate mapping; Foxd3/Pax3 compound mouse mutants; zebrafish foxd3/tfap2a double mutants\",\n      \"pmids\": [\"21228004\", \"21254333\", \"21963426\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct targets maintaining neural potential vs. repressing mesenchymal fate not distinguished genome-wide\", \"Signaling pathways mediating the Foxd3/Tfap2a synergy not fully resolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"FOXD3's relevance in cancer was established: BRAF inhibitor treatment upregulates FOXD3 in mutant-BRAF melanoma, conferring adaptive resistance to cell death and suppressing migration/invasion via direct transcriptional repression of Rnd3.\",\n      \"evidence\": \"siRNA knockdown and ectopic expression in melanoma cell lines treated with PLX4032/PLX4720; ChIP at Rnd3 promoter; ROCK inhibitor rescue\",\n      \"pmids\": [\"21996740\", \"21478267\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance of FOXD3-mediated resistance not demonstrated with genetic models\", \"Upstream mechanism of FOXD3 induction by BRAF inhibition unknown\", \"Single-lab findings for each study\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"The upstream regulation of FOXD3 itself was resolved: two distinct enhancers (NC1, NC2) drive cranial vs. vagal/trunk neural crest expression, with Pax7/Msx1/2/Ets1 directly binding NC1 and Zic1 binding NC2.\",\n      \"evidence\": \"Enhancer reporter assays in chick, in vivo ChIP, morpholino knockdowns, systematic enhancer mutagenesis\",\n      \"pmids\": [\"23284303\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether these enhancers are conserved and functional in mammals not tested\", \"How signaling pathways converge on these transcription factors at the enhancers is unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"FOXD3's tumor-suppressive transcriptional activity was expanded: it directly binds the NDRG1 promoter to activate transcription in neuroblastoma, suppressing VEGF, MMP9, and metastasis, and regulates melanocyte vs. Schwann cell precursor balance in neural crest derivatives.\",\n      \"evidence\": \"ChIP and luciferase reporter at NDRG1 promoter, NDRG1 rescue in xenografts; avian gain-of-function and mouse conditional KO with lineage tracing for fate balance\",\n      \"pmids\": [\"24269992\", \"23858437\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"NDRG1 regulation by FOXD3 shown in single lab\", \"Whether FOXD3 is silenced in primary neuroblastomas by epigenetic mechanisms needs confirmation\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"The chromatin-level mechanism of FOXD3 was defined: FOXD3 simultaneously recruits BRG1 (SWI/SNF) to open chromatin and HDAC1/2 to prevent full activation, thereby priming enhancers for future expression; it also decommissions naive-pluripotency enhancers during the ESC-to-EpiSC transition and must be silenced for primordial germ cell specification.\",\n      \"evidence\": \"ChIP-seq, ATAC-seq, co-immunoprecipitation of FOXD3 with BRG1 and HDAC1/2, conditional deletion comparing ESC and EpiSC chromatin states, RNA-seq\",\n      \"pmids\": [\"26748757\", \"26748758\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of FOXD3 interaction with BRG1 and HDAC1/2 unknown\", \"Whether the priming mechanism operates identically in neural crest cells untested\", \"Genome-wide target overlap between ESC and neural crest contexts not compared\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"FOXD3's immunomodulatory dimension in melanoma was uncovered: BRAF inhibition-induced FOXD3 reduces VISTA expression on melanoma cells, and melanoma-specific VISTA promotes tumor onset by expanding T regulatory cells and enhancing PD-L1 on tumor-infiltrating macrophages.\",\n      \"evidence\": \"FOXD3 overexpression/knockdown in melanoma cells, VISTA expression analysis, in vivo xenograft, flow cytometry of immune infiltrates\",\n      \"pmids\": [\"31940493\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether FOXD3 directly binds VISTA regulatory elements not tested (no ChIP)\", \"Single lab, in vivo model is xenograft not syngeneic/autochthonous\", \"Clinical relevance of FOXD3-VISTA axis in BRAF-inhibitor-treated patients unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: how FOXD3's enhancer-priming mechanism in ESCs relates to its function in neural crest and other progenitors; whether the same BRG1/HDAC1/2 co-recruitment operates in all FOXD3-dependent contexts; and what drives the context-dependent switch between FOXD3's activator and repressor activities at specific loci.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No genome-wide chromatin profiling of FOXD3 in neural crest cells\", \"Structural basis of FOXD3-cofactor interactions unknown\", \"In vivo genetic validation of FOXD3-mediated drug resistance in melanoma lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [7, 13, 15, 17, 18, 19, 21]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 2, 5, 6, 13, 14, 15, 18, 19, 21]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 5, 13, 14]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:74160\", \"supporting_discovery_ids\": [13, 14, 15, 18, 19, 21]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [13, 14, 15, 18, 19, 21]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [13, 14]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 2, 4, 6, 8, 9, 10, 11, 12]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"BRG1\",\n      \"HDAC1\",\n      \"HDAC2\",\n      \"PAX3\",\n      \"TFAP2A\",\n      \"PAX7\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}